Flow cytometry showed a significant increase in the amount of CD3+, CD3+CD8+, and CD8+ IFN-γ+ cells in CT26HER2 tumor tissue (Fig. 6E), which was confirmed in the MC38HER2 syngeneic model (Fig. 6F). The gene discussed is CD8A; the disease is neoplasm.